Amplifica Collabs With UK Biotech Ingenza

Last week, it was announced that Amplifica has entered into a collaborative agreement with Ingenza to further its signaling molecules through toxicity studies and into clinical trials. Ingenza is based in Edinburgh, UK and describes themselves as a company which “specializes in advancing drug development from preclinical evaluation into humans.” This latest announcement from Amplifica represents a positive step forward for the candidate molecules which currently sit in its pipeline.